Advancements in blood-based diagnostic testing for Alzheimer's disease

Recent clinical studies indicate that blood-based biomarkers are increasingly capable of diagnosing and predicting Alzheimer's disease progression. While these tests offer a less invasive alternative to traditional diagnostics, the extent to which they will alter clinical treatment protocols remains subject to further validation.